Physician profile
Sarah E Samples
NPI 1235755786
$568.95
in general payments reported to CMS, 2019-2025
10 companies · $15.45 in 2025
The $15.45 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $127 · 2023: $367 · 2024: $59.20 · 2025: $15.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $266 · Food and Beverage: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $265.82 |
| Food and Beverage | $175.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $170.76 | 2022-2025 | |
| Lilly USA, LLC | $100.87 | 2023 | Jaypirca, Retevmo |
| Janssen Biotech, INC. | $99.95 | 2023 | Imbruvica |
| Incyte Corporation | $82.44 | 2022-2023 | |
| Puma Biotechnology, INC. | $24.81 | 2022 | |
| Daiichi Sankyo INC. | $23.45 | 2024 | Enhertu |
| Celgene Corporation | $18.69 | 2023 | Opdualag |
| Array Biopharma INC | $16.94 | 2024 | Mektovi, Xalkori, Lorbrena |
| Abbvie INC. | $16.68 | 2022 | |
| Genzyme Corporation | $14.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Samples listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.